We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
While Teva Pharmaceutical and Takeda Pharmaceutical have framed a previously disclosed joint venture in Japan as a “partnership,” new details about the arrangement show that Takeda is selling off drugs for stock. Read More
A California supplement maker is in hot water after being accused of making drug-like claims about its products and relying on improper production methods. Read More
A growing number of health insurers are asking pharmaceutical manufacturers to tie payment to how a drug performs. Some drugmakers are taking the leap into this relatively unchartered territory. Read More